Company Research Report: Caranx Medical

Company Overview

• Name: Caranx Medical

• Mission of the Company: Caranx Medical aims to set new standards in medical interventions by using breakthrough solutions to standardize and democratize complex surgical procedures, improving patient outcomes and reducing risks associated with the human factor.

• Founded By: The company was founded by three co-founders who are experts in their respective areas: an entrepreneur, a clinician, and a researcher.

• Key People in the Company:

• Michel Therin, DVM, PhD - Chairman

• Jørgen Hansen, MBA - CEO

• Eric Séjor, M.D. - CMO & Co-founder

• Pierre Berthet-Rayne, PhD, Ing. - CTO & Co-founder

• Vincent Dagommer - CFO

• Headquarters: 12 Rue Jean Antoine de Baïf, Paris, 75013, France

• R&D Location: 400 Promenade des Anglais, Nice, 06200, France

• Number of Employees: Over 20 international talents.

• Revenue of the Company: No information is available.

• What is the Company Known For: Caranx Medical is known for developing the AiiR platform, which combines artificial intelligence, imaging guidance, and robotics to simplify and standardize complex endoluminal procedures.

Products

AiiR Platform

• Description: AiiR (Artificial Intelligence / Imaging / Robotic) is a cutting-edge technology solution designed to simplify, standardize, and democratize complex endoluminal procedures by integrating advanced robotic assistance, imaging, and tailored procedures.

• Key Features:

• Artificial Intelligence: Utilizes a vast multi-modal database to build digital twins for precision procedures.

• Image-Guided Intervention: Offers real-time multi-modal medical image analysis for fast decision-making.

• Robotic Assistance: Enables autonomous robot operations under clinician supervision.

TAVIPILOT

• Description: TAVIPILOT is the first robotic solution developed with the AiiR platform, focused on optimizing aortic valve procedures and improving precision in valve positioning.

• Key Features:

• Procedure Simulation: Uses digital twin technology for pre-operative planning.

• Real-Time Navigation: Controls instrument navigation to the heart based on real-time imaging.

• Precision Deployment: Achieves millimetric precision in valve delivery under clinician supervision.

Obelia Solution

• Description: Another robotic solution under the AiiR platform, dedicated to treating obesity through an endoluminal approach.

• Key Features: Developed similar in nature to TAVIPILOT with personalized, procedure accuracy.

Recent Developments

• World's First Robotic Assisted Heart Valve Implantation: On April 16, 2024, Caranx Medical announced the successful world-first robotic assisted aortic valve implantation in an animal in Nice, France. This milestone signifies a new generation of robotics in interventional cardiology.

• Innovation Award: Caranx Medical won the Innovation award at I-NOV 2023 organized by BPI France-Ademe.

• Human Factors Engineering Validation Study: In October 2024, Caranx is conducting a usability study of their TAVIPILOT system with top interventional cardiologists in Chicago and New York, marking the final step before FDA submission by the end of 2024.

Contact Information

• Headquarters: 12 Rue Jean Antoine de Baïf, Paris, 75013, France

• R&D Division: 400 Promenade des Anglais, Nice, 06200, France

• Email: contact@caranx-medical.com

• Phone: +33(0)982248561

For additional updates and detailed information, please contact Caranx Medical directly through their official channels.